Held in Brisbane in March 2022, this seminar focused on opioid-reduction strategies, safe opioid prescribing, communication between hospitals and GPs and adapting to the new Opioid Analgesic Stewardship in Acute Pain Clinical Standard.

This article considers some of contentious therapeutic therapies for refractory cancer pain and the evidence base for their use.

Early referral to a specialised pain service offers the best chance of recovery to patients with complex regional pain syndrome.

The term ‘nociplastic pain’ has been introduced as the third mechanistic descriptor for the somatic component of pain. This article defines this new term and explains the significance of its introduction.

Although pharmacotherapies are the cornerstone of managing advanced cancer pain, other biological and nonpharmacological therapies can be used in conjunction to further relieve pain.

New daily persistent headache (NDPH) is under-recognised in the community. Early diagnosis and a multidisciplinary approach to management can help patients understand the condition and strengthen the therapeutic relationship.